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Introduction
The differential diagnosis of bullous diseases in the 
pediatric years is broad, ranging from infectious 
to genetically determined blistering disorders [1]. 
Regarding acquired immunobullous diseases, they 
are extremely rare in newborns, and when present, 
are usually caused by the transplacental passage of 
autoantibodies (pemphigoid gestationis), [1, 2].
BP represents an immune mediated bullous 
disease that is manifested by urticarial plaques with 
superimposed subepidermal blisters with significant 
pruritus. It is generally found in the elderly and is rare 
in the pediatric population [1]. Among pediatric cases 
of infantile BP, three variants have been described: 
infantile (infants, usually lesions with acral location), 
childhood (children, usually more generalized 
disease), and localized vulvar disease [1].
Case Synopsis
A 5-month-old girl was observed by her pediatrician 
because of vesicles and blisters located on the hands, 
feet, and mouth. She was diagnosed as having hand-
foot-mouth disease. Owing to the appearance of 
new lesions during the following 2 weeks, she was 
presented to our dermatology department with 
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Bullous pemphigoid (BP) is an immune mediated 
bullous disease that is manifested by urticarial 
plaques with superimposed subepidermal blisters 
and significant pruritus. It is generally found in the 
elderly, but is rare in the pediatric population. A 
5-month-old girl previously diagnosed with hand-
foot-mouth disease was examined in our dermatology 
department owing to vesicles and bullae, initially 
located to the hands and feet, which progressed with 
new lesions. Tense vesicles and bullae distributed in 
an annular string of pearls pattern on the abdomen 
and facial and cervical regions were noted. Histologic 
and immunologic findings were consistent with the 
diagnosis of infantile BP. Disease control was obtained 
with oral prednisolone and dapsone; the patient was 
still in clinical remission 6 months after treatment 
cessation. The differential diagnosis of the clinical 
presentation of the lesions in our patient is of note, 
given that this blistering pattern is frequently reported 
in association with linear IgA bullous dermatosis.
Figure 1. Clinical aspect of the lesions.
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Figure 2. Clinical aspect of the lesions.
Figure 3. A, B) Hematoxylin-eosin, and C) and D) direct immunofluorescence IgG and C3, respectively. . Magnifications, A) 100x, B) 200x, 
C) 200x, D) 200x.
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several tense vesicles and bullae distributed in an 
annular string of pearls pattern on the extensor 
surface of the hands and forearms, feet, abdomen, 
and facial and cervical regions (Figures 1, 2). Nikolsky 
sign was negative and no mucosal lesions were 
present. The patient was irritable, with pruritus 
and decreased appetite. The patient was the third 
daughter of a healthy non-consanguineous couple. 
Delivery was without complications at 39 weeks and 
the mother did not suffer any dermatologic disease 
during pregnancy or the post-partum period during 
this or two previous pregnancies.
Histologic examination showed multiple eosinophils 
in the superficial dermis and subepidermal clefts 
(Figure 3A, B). Direct immunofluorescence revealed 
linear staining of IgG (Figure 3C) and C3 (Figure 3D) 
along the basement membrane; there was absence 
of IgA deposits. Anti-BP 180 antibodies were positive 
in the circulation (124 U/mL). These findings were 
consistent with the diagnosis of infantile BP.
Treatment was performed initially with topical 
corticosteroids without improvement. One week 
later, oral prednisolone (1.5mg/kg/day) was initiated. 
Dapsone (1mg/kg) was added 10 days after, owing 
to the persistent activity of the disease. Sustained 
clinical improvement occurred during the following 
4 weeks, after which slow reduction and interruption 
of therapy was performed during the following 
month. The patient was still in clinical remission 6 
months after treatment cessation.
Case Discussion
The importance of the correct diagnosis of bullous 
diseases in the pediatric years is a major issue in order 
to determine prognosis and treatment response. In 
our case, although the clinical presentation suggested 
an IgA linear bullous dermatosis (LAD), the absence 
of IgA deposits on direct immunofluorescence 
and the finding of IgG linear deposits and BP-180 
circulating antibodies led to the diagnosis of BP. 
LAD or chronic bullous disease of childhood is the 
most frequent auto-immune bullous disease in the 
pediatric age group and presents a more prolonged, 
and sometimes refractory disease, with usual clinical 
remission before puberty [3]. BP on the other hand, 
is a rare immune bullous disease in children with a 
good prognosis and excellent therapeutic response. 
Previous clinical reports have been published in 
which collision of both diseases is observed [4, 
5], an association that might be explained by the 
epitope spreading phenomenon [3]. Regarding the 
latter phenomenon, an initial inciting inflammatory 
mechanism exposes cutaneous “immunologic 
sanctuaries” (namely constituents of the basement 
membrane) that act additionally as targets to 
secondary immunologic responses [3].
In fact, two of the major antigens seen in LAD: LAD-
1 and LAD-97 represent, respectively, 120-kDa and 
97-KDa fragments of one of the major BP antigens: 
BP-180 [6]. This close immunologic relationship may 
explain why a primary disease like BP may resemble 
in some clinical settings LAD. Also the inflammatory 
infiltrate of BP may expose and modify BP-180 
protein and create new immunogenic particles that 
will be targeted by the adaptive immune system 
(with the production of specific immunoglobulins, 
namely IgA) and will be ultimately responsible for the 
development of LAD. The latter explanation would be 
an example of the epitope spreading phenomenon 
between BP and LAD.
In pediatric bullous pemphigoid, acral involvement 
(hands, feet, head) is reported as the clinical hallmark 
of the infantile form, whereas the childhood variant 
usually presents with a more diffuse involvement [1, 
7]. No established triggers were found to date for 
pediatric BP development, namely malignancies or 
drugs. The reported relation to previous vaccination 
or infection may simply represent a temporal 
coincidence given the high number of vaccines 
received in the first years of life [7]. Hand-foot-mouth 
disease has been described as a potential trigger 
of BP exacerbation in adults and may represent a 
potential activating mechanism of unregulated 
immunity [8]. Nonetheless, the fact that infantile BP 
presents in an acral distribution makes it possible for 
the initial presentation to simply mimic and lead to 
an incorrect diagnosis of hand-foot-mouth disease 
[9].
Treatment modalities for bullous pemphigoid consist 
of topical corticosteroids, systemic corticosteroids, 
dapsone, sulfapyridine, micofenolate mofetil, and 
rituximab. Relapse in not common and in general 
the prognosis is excellent [7]. Although dapsone 
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is classically viewed as an excellent treatment 
option in IgA-mediated disease, good therapeutic 
efficacy has been documented in infantile and 
adult bullous pemphigoid, especially as an adjuvant 
treatment modality [7, 10]. This fact, together with 
the ambiguous clinical presentation of our case, led 
to the choice of this double-barrelled therapeutic 
choice.
Conclusion
Delaying appropriate treatment can cause significant 
morbidity owing to weight loss, dehydration, and 
failure to thrive. Thus, early diagnosis must be 
achieved to avoid morbidity [11]. Also, associated 
symptomatic measures to reduce pruritus and treat 
co-infection are of the utmost importance [12].
The differential diagnosis of the clinical presentation 
of the lesions in our patient is of note, given that this 
blistering pattern is frequently reported in association 
with LAD [13]. We hereby describe a case of BP 
with an initial innocent and localized presentation, 
that generalized and required work up and a more 
aggressive therapeutic approach.
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